Navigation Links
Tablet PCs in Healthcare: a 1.7 Billion-Dollar Market, According to New Kalorama Report
Date:7/22/2013

New York, NY (PRWEB) July 22, 2013

The global market for tablet PC devices in healthcare is expected to increase to $1.7 billion for 2013, reflecting an increase of nearly 27% over the prior year, according to Kalorama Information. The healthcare market research publisher says several factors are driving the growth of this market including a shortage of qualified medical professionals, cost restraints, medical error reduction measures, expanding capabilities of devices, off-site medical care and more. The finding was made in Kalorama’s new report, "The Market for Tablet PCs in Healthcare."

Kalorama’s estimate included sales for tablet devices, including hybrid and convertible tablets, where medical professionals or institutions have used these devices for at least 50% health-related use. The report says that revenue growth will remained strong. The increasing adoption of tablets in the health industry will drive developers/manufacturers to continue to rollout new, advanced products, securing a healthy market for upgrades and replacement units.

"Tablet PCs are increasingly being used for a variety of tasks in the health field including access to patient records at the point of care, improved viewing capabilities for medical images, and easy offsite patient monitoring," said Melissa Elder, Kalorama analyst and the author of the report.

Viewing radiology images, ordering e-prescriptions, and filling out a patient’s EMR record are among the tasks that physicians and other healthcare professionals are using tablet PCs for in a healthcare setting, according to the report.

"These are among the devices making EMR a reality in healthcare, without them it would be difficult to pin healthcare workers to a desktop," Elder said.    

The report says that Apple’s iPad has continued to grab a larger share of the market each year, but that there are other competitors interested in the healthcare market. Among the vendors in this market are Samsung, Research in Motion (BlackBerry), Panasonic, Hewlett Packard, Motion Computing, Lenovo, Fujitsu, Tangent and others, though all are struggling to keep pace with the adoption rate of Apple.

The report, "The Market for Tablet PCs in Healthcare" has breakouts of usage of Tablet PCs and of the market by customer type (nursing home, physician offices, hospitals) and by geographic region. The report provides case studies, follows trends and profiles key companies in the market. The report can be found at: http://www.kaloramainformation.com/Tablet-PCs-Healthcare-7669302/.

About Kalorama Information

Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10930721.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Stop diabetes with insulin tablets
2. Digital tablets improve speed and ease of reading for people with moderate vision loss
3. Device helps children with disabilities access tablets
4. Duke University to Measure Altitude Sickness on Mount Everest Using MobileDemand Rugged Tablet PC
5. Android Tablet PC Mini Studio with Android 4.1 with 16GB is Here at $121 Only at Handgiftbox.com
6. ERT’s SITEpro® Tablet is Authorized to Administer Key Respiratory Quality of Life Assessments
7. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce Pure, Prescription Grade hCG Tablets, More Effective than FDA Sanctioned Homeopathic hCG Drops
8. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Introduce New hCG Drops and hCG Tablets that Eliminate Overeating While Burning Fat to Achieve Healthy Weight Loss
9. Digital Revolution in the Sales Field: How Tablets Have Become an Essential Enterprise Tool — New Ebook by Intellectsoft
10. U.S. Plans Billion-Dollar Project to Study the Brain
11. As New Premature Ejaculation Drugs Get Closer To The Public Market, LastLonger2Night.com Announces A Drug-Free Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... September 22, 2017 , ... ... the fallacy of an obligatory tithe, and the freedom experienced when breaking free ... creation of published author, Lysa M. Harrison. , Published by Christian Faith Publishing, ...
(Date:9/22/2017)... ... ... “Fruit of the Spirit: “Love””: a delightful adventure of two friends who play ... Spirit: “Love”” is the creation of published author, Halimah Jones, who was born and ... an avid writer, her inspiration for “Fruit of the Spirit: “Love”” blossomed from her ...
(Date:9/21/2017)... ... September 21, 2017 , ... With ProSlideshow Portrait from ... easy to do. Users can select from up to two layers of subject matter ... of a mouse all within Final Cut Pro X. , With ProSlideshow ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional Communication:, Keeping ...      , In the competitive world of drug and device marketing and promotion, ... with FDA rules. , The FDA has issued two draft guidances that are ...
(Date:9/21/2017)... ... September 21, 2017 , ... Innovatum will ... the Global GS1 Healthcare Conference 2017 in Chicago, IL on October 17-19, 2017. ... label quality and improving patient safety. , Microscan , a global ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... NuvoAir (formerly called Pond Healthcare Innovation), ... partnership with Novartis Pharma AG to distribute NuvoAir,s spirometry technology ... leading mobile spirometry platform and Novartis, commitment to address the ... ... ...
(Date:9/6/2017)... 6, 2017  Robert G. Szewc, M.D., is recognized ... in recognition of his contributions to the Medical field.  ... Nephrologist at the practice of Kidney and Hypertension Specialists, ... and hypertension solutions. He has worked in this position ... experience, as well as expertise in kidneys, hypertension, chronic ...
(Date:9/6/2017)... NeuroRx, a clinical stage biopharma company developing the first oral ... granted Fast Track status by the US Food and Drug ... by NRX-101 (D-cycloserine + lurasidone). The company will shortly begin ... targeting patients who are admitted to Emergency Departments with ASIB ... ...
Breaking Medicine Technology: